Madrigal Pharmaceuticals, Inc.

Bank of New York Mellon Corp MDGL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

136,869

Value ($000)

79,704

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	79,704	0.0%	136,869	12/31/2025
2025 Q3	11/3/2025	44,847	0.0%	97,779	9/30/2025
2025 Q2	8/5/2025	26,918	0.0%	88,943	6/30/2025
2025 Q1	4/29/2025	20,135	0.0%	60,789	3/31/2025
2024 Q4	2/4/2025	18,579	0.0%	60,210	12/31/2024
2024 Q3	11/12/2024	12,810	0.0%	60,361	9/30/2024
2024 Q2	7/25/2024	20,680	0.0%	73,815	6/30/2024
2024 Q1	4/25/2024	15,457	0.0%	57,883	3/31/2024
2023 Q4	1/29/2024	14,387	0.0%	62,178	12/31/2023
2023 Q3	10/24/2023	8,585	0.0%	58,786	9/30/2023
2023 Q2	8/3/2023	13,051	0.0%	56,498	6/30/2023
2023 Q1	5/9/2023	10,602	0.0%	43,762	3/31/2023
2022 Q4	2/14/2023	12,472	0.0%	42,971	12/31/2022
2022 Q3	11/14/2022	2,645	0.0%	40,702	9/30/2022
2022 Q2	8/15/2022	2,613	0.0%	36,494	6/30/2022
2022 Q1	5/11/2022	3,545	0.0%	36,127	3/31/2022
2021 Q4	2/11/2022	2,945	0.0%	34,744	12/31/2021
2021 Q3	11/18/2021	3,566	0.0%	44,697	9/30/2021
2021 Q2	8/11/2021	3,878	0.0%	39,810	6/30/2021
2021 Q1	5/13/2021	4,074	0.0%	34,827	3/31/2021
2020 Q4	2/9/2021	3,947	0.0%	35,506	12/31/2020
2020 Q3	11/12/2020	4,301	0.0%	36,220	9/30/2020
2020 Q2	8/12/2020	4,195	0.0%	37,046	6/30/2020
2020 Q1	5/6/2020	2,394	0.0%	35,863	3/31/2020
2019 Q4	2/14/2020	3,113	0.0%	34,174	12/31/2019